Tuberculosis (TB) is a serious bacterial infection that mainly affects the lungs. The bacteria spread from person to person via sneezing and cough. It is highly contagious. Most TB infections are latent (no symptoms), with about 1 in 10 having an active infection and symptoms including cough, exhaustion and more. Both latent and active TB is treatable with antibiotics but can be fatal if left untreated.
The Tuberculosis Clinical Research Group is engaged in multi-center consortium studies, investigator-initiated local research studies, and educational efforts locally, regionally, and nationally. The group is also active within the Centers for Disease Control's Tuberculosis Trials Consortium (TBTC), enrolling patients in both latent and active TB treatment trials.